CogMed Intervention Targeting Working Memory in Patients with Mild Cognitive Impairment

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memory and also helps reduce stress. The Investigators also want to see if CogMed results in changes to a blood biomarker called p-Tau 217, which possibly indicate Alzheimer's disease (AD).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• Male or female outpatients ages ≥ 50 years;

• Meet Mayo Clinic Criteria for MCI. (Patients with mild cognitive impairment)

• Access to the internet through computer

• A proficiency in speaking and reading English or having a family member who is proficient in reading and speaking English and is willing to serve as a translator.

• Vision and hearing must be sufficient to comply with study procedures.

Locations
United States
Arizona
Barrow Neurological Institute, Division of Alzheimer's Disease
RECRUITING
Phoenix
Contact Information
Primary
Yonas E Geda, M.D, MSc
yonas.geda@commonspirit.org
833-233-3073
Backup
Geetika Chahal, MBBS
geetika.chahal@commonspirit.org
602-406-7240
Time Frame
Start Date: 2024-09-16
Estimated Completion Date: 2025-09-30
Participants
Target number of participants: 10
Treatments
Experimental: Intervention Group
The Intervention Group (N = 5) Participants will be instructed to do CogMed intervention (computerized working memory activity carried out for 25 minutes daily for 5 days per week for a total of 10 weeks).
No_intervention: Control Group
The Control group(N = 5) follow there Treatment as usual(TAU). For ethical reasons, at the end of trial, the control group will also be offered the CogMed intervention.
Related Therapeutic Areas
Sponsors
Leads: St. Joseph's Hospital and Medical Center, Phoenix
Collaborators: Barrow Neurological Institute, Barrow Neurological Foundation

This content was sourced from clinicaltrials.gov